3//SEC Filing
SOFTBANK VISION FUND (AIV M2) L.P. 3
Accession 0000899243-20-008926
CIK 0001770787other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:15 PM ET
Size
9.1 KB
Accession
0000899243-20-008926
Insider Transaction Report
Form 3
SB INVESTMENT ADVISERS (UK) LTD
10% Owner
Holdings
- (indirect: See footnote)
Series D Convertible Preferred Stock
→ Class B Common Stock (1,044,932 underlying) - (indirect: See footnote)
Series C Convertible Preferred Stock
→ Class B Common Stock (2,791,300 underlying)
SOFTBANK VISION FUND (AIV M2) L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series C Convertible Preferred Stock
→ Class B Common Stock (2,791,300 underlying) - (indirect: See footnote)
Series D Convertible Preferred Stock
→ Class B Common Stock (1,044,932 underlying)
Footnotes (3)
- [F1]The Series C Convertible Preferred Stock and Series D Convertible Preferred Stock (the "Convertible Preferred Stock") automatically converts into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. There is no expiration date for the Convertible Preferred Stock.
- [F2]The Class B Common Stock is convertible at any time at the option of the holder into Class A Common Stock on a 1:1 basis and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions), and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
- [F3]Represents securities held directly by SoftBank Vision Fund (AIV M2) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for portfolio management and risk management. SBIA UK disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission that any reporting person is the beneficial owner of such shares for purposes of the Securities Exchange Act of 1934 or for any other purpose.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001805808
Filing Metadata
- Form type
- 3
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:15 PM ET
- Size
- 9.1 KB